iPath Return on Disability ETN
RODI
RODI was delisted on the 20th of December, 2022.
2 hedge funds and large institutions have $18M invested in iPath Return on Disability ETN in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
450,000% more capital invested
Capital invested by funds: $4K → $18M (+$18M)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$25.4M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| $18M | +$25.4M | +500,000 | +500,000% |
|
RODI Hedge Fund Activity: Q1 2015 in Review
2 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in iPath Return on Disability ETN (RODI) for Q1 2015, worth a combined $18M — up 450,000% from $4K a quarter earlier.
Fund positioning in RODI was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Barclays, adding an estimated $25.4M.
- 2 institutional investors held iPath Return on Disability ETN (RODI) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $18M of iPath Return on Disability ETN stock for Q1 2015, up 450,000% quarter-over-quarter.
- 0 funds opened new iPath Return on Disability ETN positions in Q1 2015 and 0 closed out.
- The largest iPath Return on Disability ETN buyer in Q1 2015 was Barclays, an estimated $25.4M added.
Based on aggregated 13F filings for Q1 2015.